Abstract
Topical 5-fluorouracil has been used as an effective treatment for porokeratosis. Upon its treatment, an inflammatory effect occurs with the topical 5-fluorouracil. We report a case of a patient with disseminated superficial actinic porokeratosis displaying a comparable inflammatory process following therapy with systemic 5-fluorouracil used to manage a metastatic breast cancer.
Original language | English (US) |
---|---|
Pages (from-to) | 190-192 |
Number of pages | 3 |
Journal | Journal of the European Academy of Dermatology and Venereology |
Volume | 17 |
Issue number | 2 |
DOIs | |
State | Published - Mar 2003 |
Externally published | Yes |
Keywords
- 5-fluorouracil
- Actinic keratosis
- Chemotherapy
- Porokeratosis
ASJC Scopus subject areas
- Dermatology
- Infectious Diseases